Tadolini, MarinaCodecasa, Luigi RuffoGarcía-García, José-MaríaBlanc, François-XavierBorisov, SergeyAlffenaar, Jan-WillemAndréjak, ClaireBachez, PierreBart, Pierre-AlexandreBelilovski, EvgenyCardoso-Landivar, JoséCentis, RosellaD'Ambrosio, LiaDe Souza-Galvão, María- LuizaDominguez-Castellano, AngelDourmane, SamirFréchet Jachym, MathildeFroissart, AntoineGiacomet, VaniaGoletti, DeliaGrard, SoazicGualano, GinaIzadifar, ArmineLe Du, DamienMarín Royo, MargaritaMazza-Stalder, JesicaMotta, IlariaOng, Catherine Wei MinPalmieri, FabrizioRivière, FrédéricRodrigo, TeresaSilva, Denise RossatoSánchez-Montalvá, AdriánSaporiti, MatteoScarpellini, PaoloSchlemmer, FrédéricSpanevello, AntonioSumarokova, ElenaTabernero, EvaTambyah, Paul AnantharajahTiberi, SimonTorre, AlessandroVisca, DinaZabaleta Murguiondo, MiguelSotgiu, GiovanniMigliori, Giovanni Battista2021-04-092021-04-092020-07-01Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 Jul 9;56(1):2001398.0903-1936http://hdl.handle.net/10668/3282Diagnostic, treatment and outcome details of 49 COVID-19 patients with concurrent or previous tuberculosis from 8 countries show varied clinical profiles.5 p.enTuberculosisImpacts on healthSequelaeCOVID-19Coronavirus infectionsCohort StudiesImpactos en la saludSecuelasInfecciones por coronavirusEstudios de cohortesPandemicsPandemiaMedical Subject Headings::Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Mycobacterium Infections::TuberculosisMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::DemographyMedical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus InfectionsMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort StudiesMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents::Antitubercular AgentsMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Vital Statistics::MortalityMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::TomographyMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::HumansMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory TechniquesActive tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesletter32457198open access10.1183/13993003.01398-20201399-3003PMC7251245